Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry
Jasmin B Kuemmerle-Deschner, Tilmann Kallinich, Joerg Henes, Birgit Kortus-Götze, Prasad T Oommen, Juergen Rech, Tobias Krickau, Frank Weller-Heinemann, Gerd Horneff, Aleš Janda, Ivan Foeldvari, Catharina Schuetz, Frank Dressler, Michael Borte, Markus Hufnagel, Florian Meier, Michael Fiene, Ioana Andreica, Julia Weber-Arden, Norbert Blank
RMD Open Feb 2024, 10 (1) e003890; DOI: 10.1136/rmdopen-2023-003890